Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BioSante Pharmaceuticals (BPAX) A little breakdown = BPAX will start moving north from here on out, peeps forgot that this was once at .38 now at .97 and your unhappy what more do you want it not POS penny where it gonna go up %1000 in one day.
Website: www.BioSantePharma.com
"Has Over 21 Products In Various Stages Of Development."
Overview
BioSante Pharmaceuticals (BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's products include LibiGel (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III clinical development according to a U.S. Food and Drug Administration (FDA) Special Protocol Assessment (SPA).
BioSante's first FDA-approved product is Elestrin (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase I and Phase II clinical trials. Other BioSante products are Bio-T-Gel, a testosterone gel for male hypogonadism, for which a New Drug Application (NDA) is pending, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development.
BPAX Investor Highlights
BPAX won U.S. clearance to sell Bio-T-Gel, a testosterone replacement therapy for men. Teva will market Bio-T-Gel for men with low testosterone. BioSante, the original developer of Bio-T-Gel, estimates the market for male testosterone products is more than $1.2 billion in the U.S., where hypogonadism affects as many as 5 million men. BioSante licensed the gel to Teva, the world’s largest generic-drug maker, and will receive milestone payments and royalties when the drug is commercialized.
Announced that the independent Data Monitoring Committee (DMC) has completed the eighth unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects. The independent DMC has recommended that the LibiGel safety study should continue as per the FDA-agreed protocol, without modifications.
As of December 31, 2011, BioSante had approximately $57 million in cash and cash equivalents and $20.8 million in principal amount of convertible notes outstanding, due on May 1, 2013. The projected burn rate for 2012 is approximately $2.5 million per month, assuming the LibiGel safety study continues.
BioSante continues to analyze the LibiGel data from the two pivotal Phase III efficacy trials first reported on December 14, 2011. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in postmenopausal women, for which there is no FDA-approved product.
BioSante’s cancer vaccines are in development for the treatment of several different types of cancer including melanoma, pancreatic, breast and prostate cancer. Currently, there are 17 Phase I and Phase II clinical studies ongoing, primarily being conducted at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland.
Recent News and Press Releases
Teva, BioSante Win FDA Approval to Sell Men’s Testosterone-Replacement Gel
BioSante Pharmaceuticals, Inc. to Present at BIO CEO & Investor Conference
BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review for Phase III Program
BioSante Exchanges $5 Million Aggregate Principal Amount of Convertible Senior Notes for 6.7 Million Shares of Common Stock
BioSante Pharmaceuticals Provides Corporate Update
For the latest Quote and News on BPAX Click Here.
BPAX Financials Approximate as of February 15, 2012
Market Cap: $84M
Outstanding Shares: 110M
52 High/ Low: $4.02 / $1.66
Price: $0.76
Ticker: BPAX
Perfect that is a really good sign once the freakin flippers out it up to strong hand to determine the price action, we are going higher from here on out, short have to cover, over 20 million shares shorted.
Come on down BPAX
BPAX OS I think it about 110 million and it not even 10:30 yet we already trade well over 22 million and if someone can check IB to see if their any shares left to short, I believe the share are all dry up so this could mean one thing we are about to launch. I like to hear FTD from IB whoever has access if possible.
OK hmm you start to sound a little off the wall there LOL, but whatever float your boat man, BPAX does have that potential as I been STIFF all week long once I found out about the T gel
""Imagine bodybuilders rubbing it all over themselves? For example""
FDA.GOV APPROVAL SITE - short in a world of hurt right now and it only getting worst by the minutes LOL
http://google2.fda.gov/search?q=BioSante+Pharmaceuticals%2C+Inc&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&output=xml_no_dtd&getfields=*
http://www.bloomberg.com/news/2012-02-14/teva-biosante-s-testosterone-gel-for-men-wins-approval-from-u-s-fda.html?cmpid=yhoo
Checkout the new it off the chain BPAX will hurt the short for ahwile
8pm est 5 pm pst now the short are at it again doing whatever it take, sorry buddy it not going to work this time, all the weak hand and mama boyz is gone, you're now playing with the big boyz. 24 million shares short hmm - i think we're on an uptrend green this whole week and next week before profit taken LOL
This is the greatest Valentine day for me!! BOOM BOOM
Once Bloomberg air about bpax and teva approval it gonna go crazy especially for stock undervalue and to these investors it freakin cheap a 1 2 3 dollar stock with FDA approval plus short covering to the tune of 24 mill shares V-DAY it is for BPAX
YEPI short the bridge is on the right LOL FARTSTICKS the rope is also their too, BPAX V-DAY payback we're going to $5 by FRIDAY no is selling and if you sell - sell it to them high here my 50k for $5 buck two wk out
CONGRATULATION TO THE BALL OF STEEL GROUP INCLUDING ME LOL
BPAX will MOASS the SHORT all weeks and next weeks.
It brilliant that the CEO did it after hours so they can screw the short, caught them off guard now they won't sleep tonight, payback to FARTSTICKS BPAX in the house of pain
HOLY FU$$K BPAX CONFIRM APPROVED
LOL WTF we're green AH another green AH useless crap again or should we see something good, question remain but WTF GO BPAX
We need link please
Sorry guys didn't see that
If we get FDA approve it will 4 or 5 by friday due to short lol
let hope we get fda approval first GO bpax
On the open market? WHOO HOO GO BPAX I think they going to halt trading pretty soon
In my opinion volume is picking up like crazy, this could only mean one thing, we got FDA APPROVAL. I told yal in my previous post they wouldn't do the conference to release bad new. SHORTER am frying you ARSE for lunch and dinner GO BPAX it your V-DAY stand for Vendetta
Get some more, the more sell off the better for the long, I can add more cheap - BPAX is going to surprise everyone, maybe after hours notice or tomorrow who know it the freakin FDA
Dude I don't pump, am the killer of the promotional quote in POS land, I try to give straight forward opinion that it GLTA BPAX will rock tomorrow
LOL yep you're right but BPAX is approved for sure read my last post of today, the CEO wouldn't hold conference to release bad new, they did cancel the last time but this time NOT so we're good.
I think this is a leak from the STREET LOL BPAX is approved hold on tight we're gonna rocket to the moon, by the mean of SHORTER help.
Scroll to the middle page- YEPI DO unless it a typo but I don't think so, my hunch was right read my last post.
http://www.thestreet.com/_yahoo/story/11381938/1/play-ithestreetsi-fda-drug-approval-contest.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
Feb. 14: BioSante Pharmaceuticals'(BPAX_) Bio-T-Gel for hypogonadism APPROVED
BPAX riding the FDA approval tomorrow and here why?
The last time that BPAX had an investor conference scheduled, they cancelled it due to the bad news of Libigel. Now, they are scheduled to make a presentation at the "Big Daddy" of them all. Common sense says that they will not announce bad news at this conference. The press release was this morning and they've had plenty of time to cancel. They have not cancelled and this is great news! I believed other thing might unfold also, maybe a buyout possibility from TEVA would be nice or partnership with other Biotech. Here my thing about the "The Street" and A. FARTSTICK loud mouth SOB - he has no degree in biotech and he doesn't know jack and nothing more than a bunch of crook stock manipulator, should be trial and hung. Let see where BPAX will be and if my hunch is correct we rock and screw the short.
YEP FEB 14 presentation and also FDA hmm sound like something is cooking really good, and am loving it and I feel shorter will get even shorter as we pound them to death. GO BPAX
But even if they close it out for you, they just charge some fee but you still earn your keep, if you let your option in the money expire out.
BPAX is at a neutral zone, if the FDA approve it gonna skyrocket to tha moon if you notice the support level is in the high eighties because investors unsure of what to do, they don't want to sell and they don't buy up but if it dip they got the sideline ready to pick them up just like that. Well I hope FDA do get approved next week so us long on this board can rock, and burn short to crispy fried, if not take a little hit and wait but for whatever it worth I like chance GLTA
I think if the FDA doesn't approved BPAX it will go down to support level in the .60 to .70 range it been beaten to death, it can't go down anymore than that, why because BPAX has other drug in the pipeline, partner with some heavy hitter in the business, just because one drug it not going to destroy the company, which everyone seem to think BPAX will die if they don't get approve on FEB 14 -- Here your SIGN if you think BPAX T-gel has no affect, well am STIFF right now just thinking about it,
Just check mind nope it there all there hard as STEEL - get ready to open the flood gate Tsunami is coming for ya SHORTERS ready to cover or you DIE WAUHAAA WAUHAAA GO BPAX GO BPAX
YEP right there with ya, we rock from here on out yahoo put out an INPLAY release also on BPAX
YAHOO
INPLAY:7:55AM BioSante reports 'positive' LibiGel safety data review for Phase III program (BPAX) 0.84 : Co announced that the independent Data Monitoring Committee has completed the eighth unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects. The independent DMC has recommended that the LibiGel safety study should continue as per the FDA-agreed protocol, without modifications. LibiGel (testosterone gel) is in development for the treatment of female sexual dysfunction, specifically, hypoactive sexual desire disorder in menopausal women.
OH man new is out all over the wire and positive new too, we gonna rock now - GO BPAX let shove this into the street face.
Better start getting some over $1 is TODAY
Get ready for the CHOO CHOO Train - we got some some going
BPAX let get some WEEEEEEEEEEEEEEEEEEE WEEEEEEEEEEEEEEEEEEEE WEEEEEEEEEEE WEEEEEEEEEEEEEEEEE WEEEEEEEEEEEEEEEEEE WEEEEEEEEEEEEEEEEE
BPAX is about to go PARABOLIC on the short - we're going to $1 EOD and tomorrow winner winner chicken dinner baby!
BPAX is closing over $1 TO FREAKIN DAY AND tomorrow and FRI we might get word from the FDA this my explanation for the surge RIGHT NOW G!! PEEPS that shorter
That a big IF maybe
What if they know FDA might approved their CHIT and they want revenge on the SHORT? What if they want to buy as much as possible
There if in everything - LOL am only looking for $2 and am happy which could blow up even hard but am not greedy
11:15AM BioSante exchanges $5 million aggregate principal amount of convertible senior notes for 6.7 million shares of common stock (BPAX) 0.81 -0.05 : Co announced that the company has entered into a privately-negotiated securities exchange agreement with a holder of BioSante's 3.125% convertible senior notes due May 1, 2013. Pursuant to the terms of the agreement, BioSante issued 6.7 mln shares of its common stock to the note holder in exchange for an aggregate of $5.0 mln principal amount of notes, including accrued and unpaid interest. Following such exchange, an aggregate of $15.8 million principal amount of the notes will remain outstanding.
This new today seem to scare peoples off a lot but i look at as if the executive know something is coming and they want as much as pssible for the run plus short covering too it gonna snow hard
BPAX is moving north sweeping shorter in it path.
YEP am with you there man, let go peoples man I hope BPAX does get approved and screw the short and the bashers, they ney Sayer where they're remember as one of their worst nightmare in their trading history so they pass on to their grand kids LOL
YEP two face SOB yeah I know he wrote it and so does a bunch of other crap he put out, peoples need to realized what they own and not to follow the herds I guess but oh well BPAX will have it day
http://www.thestreet.com/story/11405126/7/6-drug-stocks-unworthy-of-biotech-bull-market.html
Here the link if anyone disagree tell me why and backup your CHIT
These are doctor working their ARSE for a cure and i can understand FDA get denied all the time but shouldn't be trashing because you fel like talking out of your ARSE Let me get a WEEEEEE WEEEEEEE
GO BPAX
WOW this is the biggest BS slandering POS by the street on BPAX, thestreet.com/story/11405126… Weather the COMPANY is worthy or not you can't write chit LIKE THAT without proof or statistic to backup your claim - at least the company is trying to do something for woman with problem GO BPAX
This is a real company trying to help men and women with sexual disorder problem whether it take five tried or more it no way a professional analysis can go on a rampage/rant talking out of their ARSE like that - the street should be sue
Could TEVA be eying BPAX cancer pipeline? See link below possibility but I think BPAX got alot of believer than unbeliever.
http://seekingalpha.com/article/343151-2-biotechs-on-teva-s-radar-screen?source=yahoo